GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Avita 4735.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

35.55

+1.28%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Avita

Its shares trade on Taipei Exchange under the ticker 4735.TWO. It has been listed since 27 April 2010. In the fiscal year to 31 December 2025, it reported revenue of TWD 936.4m and net income of TWD 93.2m. At that date it held total assets of TWD 1.35bn and shareholders' equity of TWD 996.0m.

Avita Corp. manufactures and distributes point-of-care health products. The company is headquartered in Taipei, New Taipei. The company went IPO on 2010-04-27. The firm's major products include infrared ear thermometers, thermometers, electronic sphygmomanometers, nasal aspirators and others. The firm distributes its products in Taiwan market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
27 Apr 2010

Leadership

Pay as last reported

  • Mr. Minghui ZhuangChairman of the Board, since 2003
  • Mr. Qiang JiVice Chairman of the Board, General Manager
  • Mr. Zhongjie ZhuangChief Financial Officer, Corporate Governance Officer
  • Mr. Xing OuyangChief Technology Officer, Senior Deputy General Manager
  • Qiugui ChenHead of Accounting
  • Mr. Chaoming LiuDirector
  • Ms. Yiling ZhuangDirector
  • Mr. Futian JiangIndependent Director
  • Mr. Wenzheng LinIndependent Director
  • Mr. Shengchang ZhanIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Taipei, Taiwan, with a focus on health care sector.
  • Offers a range of point-of-care health products including thermometers and sphygmomanometers.
  • Has been publicly traded since 2010-04-27 with a listed ticker 4735.TWO.

Weaknesses

  • Relies on a limited product range including infrared ear thermometers and nasal aspirators.
  • Distributes products primarily in Taiwan and overseas markets without specifying market share.
  • No information provided on financial performance or market position beyond IPO date.

Opportunities

  • Expanding distribution to new overseas markets beyond current reach.
  • Potential to develop new point-of-care health products for growing health care demand.
  • Leveraging public listing to attract investment for product innovation.

Threats

  • Competition from other health care product manufacturers in Taiwan and global markets.
  • Dependence on a narrow product portfolio may limit growth opportunities.
  • Unspecified risks associated with overseas market distribution and regulatory environments.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.